✦ LIBER ✦

Discovery and identification of PIM-1 kinase inhibitors through a hybrid screening approach

✍ Scribed by Shao, Mingfeng; Yuan, Yiming; Yu, Kun; Lei, Kai; Zhu, Guonian; Chen, Lijuan; Xiang, Mingli

Book ID: 121554148
Publisher: Springer
Year: 2014
Tongue: English
Weight: 911 KB
Volume: 18
Category: Article
ISSN: 1381-1991
DOI: 10.1007/s11030-014-9504-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Identification of Novel Polo-like Kinase

Identification of Novel Polo-like Kinase 1 Inhibitors by a Hybrid Virtual Screening

✍ Shuai Lu; Shan-Liang Sun; Hai-Chun Liu; Ya-Dong Chen; Hao-Liang Yuan; Yi-Ping Ga 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 567 KB

414 POSTER Discovery and characterizatio

414 POSTER Discovery and characterization of a small molecule inhibitor for pim-1 kinase

✍ D. Bearss; C. Grand; J. Lamb; M. Lloyd; H. Vankayalapati 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Discovery of pyrazolo[1,5-a]pyrimidine-b

Discovery of pyrazolo[1,5-a]pyrimidine-based Pim inhibitors: A template-based approach

✍ Dwyer, Michael P.; Keertikar, Kartik; Paruch, Kamil; Alvarez, Carmen; Labroli, M 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 616 KB

Identification and Structure—Activity Re

Identification and Structure—Activity Relationships of Substituted Pyridones as Inhibitors of Pim-1 Kinase.

✍ I. Wayne Cheney; Shunqi Yan; Todd Appleby; Heli Walker; Todd Vo; Nanhua Yao; Rob 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 23 KB 👁 2 views

Identification of novel mPGES-1 inhibito

Identification of novel mPGES-1 inhibitors through screening of a chemical library

✍ Park, Sung-Jun; Han, Seong-Gu; Ahsan, Hafiz Muhammad; Lee, Kijae; Lee, Jae Yeol; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 870 KB

Discovery of novel class 1 phosphatidyli

Discovery of novel class 1 phosphatidylinositide 3-kinases (PI3K) fragment inhibitors through structure-based virtual screening

✍ Fabrizio Giordanetto; Bengt Kull; Anita Dellsén 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 1002 KB

The discovery of ligand efficient and lipophilicity efficient fragment inhibitors of class 1 phosphatidylinositide 3-kinases (PI3K) is reported. A fragment version of the AstraZeneca compound bank was docked to a homology model of the PI3K p110β isoform. Interaction-based scoring of the predicted bi